tiprankstipranks
Trending News
More News >
Brainstorm Cell Therapeutics (BCLI)
:BCLI
US Market

Brainstorm Cell Therapeutics (BCLI) Income Statement

Compare
562 Followers

Brainstorm Cell Therapeutics Income Statement

Last quarter (Q4 2024), Brainstorm Cell Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Brainstorm Cell Therapeutics's net income was $-2.97M. See Brainstorm Cell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 849.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 849.00K$ -265.00K$ -285.00K$ -260.00K$ -219.00K
Operating Expenses
$ 0.00$ 21.17M$ 24.82M$ 24.54M$ 31.68M
Depreciation and Amortization
$ 0.00$ 265.00K$ 285.00K$ 260.00K$ 219.00K
EBITDA
$ 0.00$ -16.93M$ -23.99M$ -24.28M$ -31.46M
Operating Income
$ 0.00$ -21.44M$ -24.82M$ -24.54M$ -31.68M
Other Income/Expenses
$ 0.00$ 4.25M$ 545.00K$ 82.00K$ -127.00K
Pretax Income
$ 11.62M$ -17.19M$ -24.28M$ -24.46M$ -31.81M
Net Income
$ 11.62M$ -17.19M$ -24.28M$ -24.46M$ -31.81M
Per Share Metrics
Basic EPS
$ 2.19$ -0.40$ -0.66$ -0.68$ -1.07
Diluted EPS
$ 2.19$ -0.40$ -0.66$ -0.68$ -1.07
Weighted Average Shares Outstanding
5.31M 42.98M 36.51M 36.18M 29.85M
Weighted Average Shares Outstanding (Diluted)
5.31M 43.08M 36.51M 36.18M 29.85M
Currency in USD

Brainstorm Cell Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis